Incannex Healthcare Inc ADR (IXHL)

$0.48 +0.02 (4.74%)
Market Cap 13.54M
Revenue (ttm) 10,000.00
Net Income (ttm) -18.46M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -184,600.00%
Debt to Equity Ratio 3.89
Volume 26,891,600
Avg Vol 104,256,102
Day's Range N/A - N/A
Shares Out 29.43M
Stochastic %K 30%
Beta 7.50
Analysts Hold
Price Target N/A

Company Profile

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety diso...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 61 4 0984 0786
Address:
8 Century Circuit, Suite 105 Norwest, Sydney, Australia
3percentperday
3percentperday Oct. 4 at 9:21 PM
$BURU $IMG $IXHL $PLUG $OPEN
0 · Reply
va4f6
va4f6 Oct. 4 at 9:16 PM
$IXHL $BURU $PLUG $IMG
0 · Reply
va4f6
va4f6 Oct. 4 at 9:16 PM
$IXHL $BURU $DFLI $ASNS $PLUG
1 · Reply
va4f6
va4f6 Oct. 4 at 9:16 PM
$IXHL $DFLI $IMG $FUBO $OPEN
0 · Reply
va4f6
va4f6 Oct. 4 at 9:16 PM
$IXHL $PLUG $IMG $BURU $DFLI
0 · Reply
va4f6
va4f6 Oct. 4 at 9:16 PM
$IXHL $BURU $IMG $DFLI $PLUG
0 · Reply
va4f6
va4f6 Oct. 4 at 9:16 PM
$IXHL $INTC $OPEN $NVDA $TSLA
0 · Reply
va4f6
va4f6 Oct. 4 at 9:16 PM
$IXHL $PLUG $IMG $LAC $DFLI
0 · Reply
va4f6
va4f6 Oct. 4 at 9:16 PM
$IXHL $BURU $IMG $GPUS $CHR
0 · Reply
va4f6
va4f6 Oct. 4 at 9:15 PM
$IXHL $BURU $AMD $TSLA $INTC
0 · Reply
Latest News on IXHL
Incannex Reports Positive Results from Phase 2 Clinical Trial of PSX-001 (Psi-GAD) for Generalised Anxiety Disorder

Aug 26, 2025, 8:00 AM EDT - 5 weeks ago

Incannex Reports Positive Results from Phase 2 Clinical Trial of PSX-001 (Psi-GAD) for Generalised Anxiety Disorder

Incannex Healthcare Authorizes $20 Million Share Repurchase Program

Aug 22, 2025, 8:00 AM EDT - 6 weeks ago

Incannex Healthcare Authorizes $20 Million Share Repurchase Program

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - Update

Aug 19, 2025, 4:29 PM EDT - 6 weeks ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - Update

Incannex Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea

Aug 8, 2025, 8:00 AM EDT - 2 months ago

Incannex Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea

Incannex Confirms Strong Cash Position; No Plans or Requirement to Fully Utilise ATM in Near Term

Jul 31, 2025, 8:00 AM EDT - 2 months ago

Incannex Confirms Strong Cash Position; No Plans or Requirement to Fully Utilise ATM in Near Term

Nano-Cap Incannex's Sleep Apnea Candidate Shows Effectiveness And Safety In Mid-Stage Trial

Jul 30, 2025, 10:10 AM EDT - 2 months ago

Nano-Cap Incannex's Sleep Apnea Candidate Shows Effectiveness And Safety In Mid-Stage Trial

Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X

Jul 30, 2025, 8:00 AM EDT - 2 months ago

Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Charlene E. Gamaldo

Jul 25, 2025, 7:30 AM EDT - 2 months ago

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Charlene E. Gamaldo

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch

Jun 24, 2025, 7:30 AM EDT - 3 months ago

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch

Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X

Jun 18, 2025, 7:30 AM EDT - 3 months ago

Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X

Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy

Jun 17, 2025, 7:30 AM EDT - 3 months ago

Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy

Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution

Jun 12, 2025, 7:30 AM EDT - 4 months ago

Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution

Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program

Jun 3, 2025, 7:30 AM EDT - 4 months ago

Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program

Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance

May 29, 2025, 7:30 AM EDT - 4 months ago

Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025

May 28, 2025, 4:21 PM EDT - 4 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025

Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results

May 28, 2025, 7:00 AM EDT - 4 months ago

Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results

Incannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential Dilution

May 20, 2025, 7:30 AM EDT - 4 months ago

Incannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential Dilution

Incannex Announces Potential Reduction of Up to 50.4% of its Series A Warrants

May 16, 2025, 9:00 AM EDT - 5 months ago

Incannex Announces Potential Reduction of Up to 50.4% of its Series A Warrants

Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates

May 15, 2025, 8:00 AM EDT - 5 months ago

Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates

Incannex Healthcare (IXHL) Stock Soars Over 800%: What's Going On?

May 14, 2025, 4:14 PM EDT - 5 months ago

Incannex Healthcare (IXHL) Stock Soars Over 800%: What's Going On?

Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

May 14, 2025, 8:00 AM EDT - 5 months ago

Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Apr 3, 2025, 7:30 AM EDT - 6 months ago

Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules

Mar 7, 2025, 2:10 PM EST - 7 months ago

Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025

Feb 18, 2025, 5:51 PM EST - 8 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025

Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates

Feb 14, 2025, 7:30 AM EST - 8 months ago

Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates

Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board

Feb 4, 2025, 9:15 AM EST - 8 months ago

Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board

Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea

Jan 23, 2025, 7:30 AM EST - 9 months ago

Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025

Dec 2, 2024, 4:48 PM EST - 10 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025

Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates

Nov 14, 2024, 4:05 PM EST - 11 months ago

Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates

Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer

Oct 24, 2024, 7:30 AM EDT - 1 year ago

Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer

Stonegate Initiates Coverage on Incannex Healthcare Inc. (IXHL)

Oct 2, 2024, 4:50 PM EDT - 1 year ago

Stonegate Initiates Coverage on Incannex Healthcare Inc. (IXHL)

Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates

Sep 30, 2024, 4:01 PM EDT - 1 year ago

Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates

Sleep Apnea Pill: Quantum Research Survey Shows Sleep Apnea Patients Seeking CPAP Alternatives

Sep 9, 2024, 8:00 AM EDT - 1 year ago

Sleep Apnea Pill: Quantum Research Survey Shows Sleep Apnea Patients Seeking CPAP Alternatives

FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed

Aug 5, 2024, 7:30 AM EDT - 1 year ago

FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed

Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X

Jul 30, 2024, 7:30 AM EDT - 1 year ago

Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X

Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

May 30, 2024, 7:30 AM EDT - 1 year ago

Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder

May 7, 2024, 7:30 AM EDT - 1 year ago

Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorder

Stonegate Healthcare Partners Releases Report on Potentially Transformative Therapies for Generalized Anxiety Disorder (GAD)

May 1, 2024, 2:33 PM EDT - 1 year ago

Stonegate Healthcare Partners Releases Report on Potentially Transformative Therapies for Generalized Anxiety Disorder (GAD)

Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation

Feb 16, 2024, 7:30 AM EST - 1 year ago

Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation

Clarion Clinics Open for Psychedelic-Assisted Treatments

Feb 1, 2024, 7:30 AM EST - 1 year ago

Clarion Clinics Open for Psychedelic-Assisted Treatments

Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis

Jan 24, 2024, 4:05 PM EST - 1 year ago

Incannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid Arthritis

Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD” Clinical Trial Assessing Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis Commences

Jan 18, 2024, 8:22 AM EST - 1 year ago

Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD” Clinical Trial Assessing Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis Commences

Incannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

Jan 17, 2024, 7:30 AM EST - 1 year ago

Incannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep Apnea

Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia

Dec 21, 2023, 4:05 PM EST - 1 year ago

Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia

Incannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep Apnea

Dec 6, 2023, 7:30 AM EST - 1 year ago

Incannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep Apnea

Incannex Healthcare Announces Completion of its Redomiciliation to the United States

Nov 29, 2023, 1:40 PM EST - 2 years ago

Incannex Healthcare Announces Completion of its Redomiciliation to the United States

Federal Court of Australia Approves Incannex's Re-Domiciliation and Lodgement of Court Orders With ASIC

Nov 16, 2023, 8:30 AM EST - 2 years ago

Federal Court of Australia Approves Incannex's Re-Domiciliation and Lodgement of Court Orders With ASIC

Incannex Announces Participation at the H.C. Wainwright 25th Annual Global Investment Conference - September 11-13, 2023

Sep 8, 2023, 7:30 AM EDT - 2 years ago

Incannex Announces Participation at the H.C. Wainwright 25th Annual Global Investment Conference - September 11-13, 2023

Incannex to Prepare FDA IND Application for Psilocybin-assisted Psychedelic Psychotherapy Program, Known as Psi-GAD

Aug 24, 2023, 7:30 AM EDT - 2 years ago

Incannex to Prepare FDA IND Application for Psilocybin-assisted Psychedelic Psychotherapy Program, Known as Psi-GAD

Review of IND Application for IHL-42X by US FDA has been completed; Clinical Trial for Patients with Obstructive Sleep Apnoea May Proceed

Aug 22, 2023, 7:30 AM EDT - 2 years ago

Review of IND Application for IHL-42X by US FDA has been completed; Clinical Trial for Patients with Obstructive Sleep Apnoea May Proceed

3percentperday
3percentperday Oct. 4 at 9:21 PM
$BURU $IMG $IXHL $PLUG $OPEN
0 · Reply
va4f6
va4f6 Oct. 4 at 9:16 PM
$IXHL $BURU $PLUG $IMG
0 · Reply
va4f6
va4f6 Oct. 4 at 9:16 PM
$IXHL $BURU $DFLI $ASNS $PLUG
1 · Reply
va4f6
va4f6 Oct. 4 at 9:16 PM
$IXHL $DFLI $IMG $FUBO $OPEN
0 · Reply
va4f6
va4f6 Oct. 4 at 9:16 PM
$IXHL $PLUG $IMG $BURU $DFLI
0 · Reply
va4f6
va4f6 Oct. 4 at 9:16 PM
$IXHL $BURU $IMG $DFLI $PLUG
0 · Reply
va4f6
va4f6 Oct. 4 at 9:16 PM
$IXHL $INTC $OPEN $NVDA $TSLA
0 · Reply
va4f6
va4f6 Oct. 4 at 9:16 PM
$IXHL $PLUG $IMG $LAC $DFLI
0 · Reply
va4f6
va4f6 Oct. 4 at 9:16 PM
$IXHL $BURU $IMG $GPUS $CHR
0 · Reply
va4f6
va4f6 Oct. 4 at 9:15 PM
$IXHL $BURU $AMD $TSLA $INTC
0 · Reply
va4f6
va4f6 Oct. 4 at 9:14 PM
$IXHL @Laurapicksright Lets go this week!! https://ir.incannex.com/news-releases/news-release-details/incannex-healthcare-authorizes-20-million-share-repurchase
0 · Reply
ThrawnVestor
ThrawnVestor Oct. 4 at 9:12 PM
$IXHL
0 · Reply
va4f6
va4f6 Oct. 4 at 9:10 PM
$IXHL
0 · Reply
cchronobreak
cchronobreak Oct. 4 at 9:10 PM
$IXHL
0 · Reply
va4f6
va4f6 Oct. 4 at 9:09 PM
$IXHL (212) 813-3700 Everybody call and Leave a message!! https://en.wikipedia.org/wiki/Pershing_Square_Capital_Management
0 · Reply
va4f6
va4f6 Oct. 4 at 9:01 PM
$IXHL I left a message. press 0 and let the DD fly!! located on 11th ave great pizza around the corner to.
0 · Reply
Joel50jp
Joel50jp Oct. 4 at 8:57 PM
$IXHL
0 · Reply
Faketeolaflare
Faketeolaflare Oct. 4 at 8:53 PM
$BINI $HOLO $IXHL $MLGO
0 · Reply
va4f6
va4f6 Oct. 4 at 8:52 PM
$IXHL Come on Joel there backs are now against the wall!! Get the puff rockets ready!!! https://scetv.pbslearningmedia.org/resource/9ff8edd9-e521-4536-af8f-fb83adff279c/puff-rocket-stem-alive/
0 · Reply
CaliCrypto
CaliCrypto Oct. 4 at 8:44 PM
$IXHL 👀 Next Week…
0 · Reply
cchronobreak
cchronobreak Oct. 4 at 8:43 PM
$IXHL
0 · Reply
va4f6
va4f6 Oct. 4 at 8:34 PM
$IXHL
0 · Reply